SUPPLEMENTAL MATERIAL. Materials and Methods. Study design

Size: px
Start display at page:

Download "SUPPLEMENTAL MATERIAL. Materials and Methods. Study design"

Transcription

1 SUPPLEMENTAL MATERIAL Materials and Methods Study design The ELSA-Brasil design and concepts have been detailed elsewhere 1. The ELSA-Brasil is a cohort study of active or retired 15,105 civil servants, aged 35 to 74 years, from six cities (São Paulo, Belo Horizonte, Porto Alegre, Salvador, Rio de Janeiro, and Vitória) in different Brazilian regions. Baseline assessment was a 7-hour onsite examination that included validated questionnaires, clinical and laboratory exams. This assessment took place from August 2008 to December We performed anthropometric measurements, including neck, waist and hip circumferences, using standard protocols. Bodymass index was calculated as weight (in kilograms) divided by the square of height (in meters). Blood samples, after an overnight fast, were collected in-site, frozen and sent for centralized analysis in the São Paulo ELSA-Brasil center. Oral glucose tolerance test was performed, two hours after a standard glucose oral intake (75g) only in previously non-diabetic participants. Approvals from institutional review boards of all centers were granted, and all individuals signed informed consent. Carotid IMT measurement A detailed protocol was published earlier 2,3. The same protocol was performed in all centers using a Toshiba (Aplio XG ) with a 7.5 MHz linear transducer. IMT was measured in the outer wall of a pre-defined carotid segment of 1 cm in length from 1 cm below carotid bifurcation, during three cardiac cycles. All participating centers obtained the carotid images and sent these acquisitions to the centralized core reading center in São Paulo. We considered as valid acquired images that clearly visualized on both the left and right sides (1) the anatomic guides for the common carotid arteries, (2) interfaces between the lumen and the vessel far wall and (3) interfaces between the media and the adventitia layers of the far vessel wall. We used MIA software to standardize the reading and interpretation of carotid scans. Study sample Of 15,105 ELSA-Brasil participants, 10,943 (72.4%) underwent IMT measurements and had adequate image quality for analysis for both CCA. We excluded 415 (2.7%) participants because of reported Asian or Indigenous race, as the low number would not allow accurate modelling, and 392 (2.6%) who reported previous myocardial infarction, stroke or revascularization. Additionally, 344 (2.3%) individuals were excluded due to any missing information on study variables. Therefore, our study sample consisted of 9,792 individuals with complete data. 1

2 Study variables In this paper, we defined CCA-IMT as the average of the mean left CCA- IMT and the mean right CCA-IMT values within an individual. CCA-IMT was used as the dependent variable in all models. Smoking status was self-reported. Hypertension was defined as the use of medications to treat hypertension, systolic blood pressure 140 mmhg or diastolic blood pressure 90 mmhg. Diabetes was defined as having a medical history of diabetes, use of medications to treat diabetes, a fasting glucose 126mg/dl, glycated hemoglobin (HbA1C) levels 6.5% or a 2h-oral glucose tolerance test 200mg/dl. Dyslipidemia was defined as use of lipid-lowering treatment or a LDL cholesterol level 130mg/dl. Family history of premature CVD refers to a diagnosis of myocardial infarction, stroke, revascularization or sudden death in a first-degree relative before age year coronary heart disease risk was calculated according to the Framingham Heart Study (FHS) risk score 4 and stratified as low (<10%) and intermediate-to-high ( 10%) 10-year coronary heart disease risk. Individuals with no traditional risk factors were defined as those without hypertension, diabetes or dyslipidemia diagnosis who did not take any cardiovascular medications, were not past nor current smokers, reported no family history of premature CVD, had a body-mass index < 30 kg/m 2 and a 10- year coronary heart disease risk < 10%. For this group with no traditional risk factors, to ensure maximum specificity, we opted also to exclude participants with reported angina pectoris. Statistical analysis Categorical variables are presented as proportions and compared using chi-squared tests. Except for age, we present continuous variables as mean ± standard deviations and they are compared using Student s t-test. ELSA-Brasil included individuals aged 35 to 74 years with inclusion goals according to age strata 5. Therefore, age has a marked non-normal distribution in the sample. We present medians and interquartile ranges for this variable within groups and compare them using the Kruskal-Wallis test. We built multiple linear regression models using CCA-IMT as the dependent variable to study how much of its variance was due to traditional cardiovascular risk factors. We used the coefficient of determination (Rsquared, R 2 ) as the main measurement for this purpose. All models were stratified by sex. We also analyze individuals stratified by 10-year coronary heart disease risk and, in separate, those with no traditional risk factors In regression models, all continuous variables except for CCA-IMT and age, were standardized to a mean at zero and standard deviation of one. Model 1 included age and race. Model 2 also included the diagnosis of hypertension, diabetes, dyslipidemia, smoking status and family history of premature CVD. In model 3 (main model), we added variables for blood pressure, glucose metabolism, lipid profile and adiposity that could further explain IMT variance (Supplemental Table I). Because of the expected high co-linearity among variables within each group, we built an iterative algorithm that chose the model with the highest R 2 among the possible combinations of only one variable from each group along with the variables already included in the previous model. We tested all models for heteroskedasticity using the Breusch-Pagan test. In all the 2

3 cases in which the test rejected the null hypothesis, we calculated standard errors and p-values using White-corrected covariance matrices. We examined the diagnostic plots and performed a systematic search for potential influential points in the main models described in the article using the following four measurements: DFFITS, Cook s distance, leverage values and covariance ratio. We performed a sensitivity analysis excluding the observations identified as potential influential points in any of these procedures. To support our decision to include only one variable from each group in supplemental table I in main models, and to quantify the impact of such decision in R 2 values, we further explored the problem of multi-collinearity in our data. We fitted post-hoc models including all possible variables to verify the highest R 2 obtained with this strategy and the highest increase in R 2 compared to the correspondent main model. We also calculated the variance inflation factor for these post-hoc models, excluding mean blood pressure and pulse pressure, already known as linear combinations of systolic and diastolic blood pressures. In another posthoc analysis, after observing that neck circumference was the main adiposity measurement contributing to CCA-IMT, we fitted models including CCA vessel diameters and body-mass index as independent variables to determine whether the association between CCA-IMT and neck circumference remained significant after adjusting for these variables. As a complementary analysis, we present as supplemental material the results of a simulated scenario where new information (as the emergence of novel risk factors) may rise the proportion of explained variance of CCA-IMT to 0.5. We compared the performance of main models and simulated models to correctly classify individuals as above (or equal) the 75 th percentile of CCA-IMT (P75) or below P75 in each subsample. For this purpose, we aimed to calculate point estimate predictions, 95% [95%PI] and 99% [99%PI] prediction intervals for each individual, for both real and simulated models. We considered that prediction intervals were correct only if all the predicting range would correctly classify the subject. We adopted the following procedure, for each subsample: (1) We calculated the point estimate prediction and prediction intervals for each subject in the subsample according to the main models. (2) We calculated P75 for the subsample. (3) We indicate the number of individuals with a predicted value, 95%PI and 99%PI above P75. (4) We calculate the proportions of correct classifications for individuals with CCA-IMT above P75, below P75 and overall. In this case, we considered as correct classifications for the 95%PI and 99%PI when the entire interval range indicated a correct classification. (5) To simulate the scenario where novel risk factor(s) increase the proportion of explained variance to approximately 50%, we built a new variable calculated as the actual CCA-IMT value for each individual plus an error with normal distribution, expected value at zero and variance V. We expected with the inclusion of the new variable that, when V equals zero, R 2 would equal 1.0; for very high values of V, R 2 would be substantially unchanged from the observed in the main real model (since the new variable would be only weakly associated with CCA- IMT). To select V, we built an iterative algorithm that simulated models with the new variable 100 times, from a starting value V=1, and aiming a mean R 2 value between and If mean R 2 for these 100 simulations was not within this range, V value was changed accordingly. (6) We simulated the new variable and included it in the model. We calculated the same indicators of 3

4 performance described for the main model. We repeated this simulation 100 times and report the mean values as the measurements of performance for the simulated model. (7) We also calculate the difference in overall accuracy (proportion of correct predictions) from the main model to the simulated model (point estimate, 95%PI and 99%PI). Significance level was set at We used R software version for analyses 6. References 1. Schmidt MI, Duncan BB, Mill JG, Lotufo PA, Chor D, Barreto SM, Aquino EM, Passos VM, Matos SM, Molina MD, Carvalho MS, Bensenor IM. Cohort profile: Longitudinal Study of Adult Health (ELSA-Brasil). Int J Epidemiol Santos IS, Bittencourt MS, Oliveira IR, Souza AG, Meireles DP, Rundek T, Foppa M, Bezerra DC, Freire CM, Roelke LH, Carrilho S, Benseñor IM, Lotufo PA. Carotid intima-media thickness value distributions in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Atherosclerosis. 2014;237: Mill JG, Pinto K, Griep RH, Goulart A, Foppa M, Lotufo PA, Maestri MK, Ribeiro AL, Andreão RV, Dantas EM, Oliveira I, Fuchs SC, Cunha ReS, Bensenor IM. [Medical assessments and measurements in ELSA-Brasil]. Rev Saude Publica. 2013;47 Suppl 2: Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97: Aquino EM, Barreto SM, Bensenor IM, Carvalho MS, Chor D, Duncan BB, Lotufo PA, Mill JG, Molina MeC, Mota EL, Passos VM, Schmidt MI, Szklo M. Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): Objectives and design. Am J Epidemiol. 2012;175: R Development Core Team. R: A language and environment for statistical computing

5 Supplemental table I. Blood pressure, glucose metabolism, lipid profile and adiposity variables included in linear regression models. Blood pressure Systolic blood pressure Diastolic blood pressure Mean blood pressure Pulse pressure Lipid profile LDL-cholesterol HDL-cholesterol Triglycerides LDL/HDL ratio Triglycerides/HDL ratio Glucose metabolism Fasting plasma glucose Glycated hemoglobin Adiposity Body-mass index Waist circumference Hip circumference Neck circumference Waist-to-hip ratio Waist-to-height ratio 5

Clinical Investigations

Clinical Investigations Clinical Investigations Implications of the New US Cholesterol Guidelines in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) Address for correspondence: Marcio Sommer Bittencourt, MD University

More information

Correlation Between the Intima Media Thickness of the Proximal and Distal Common Carotids

Correlation Between the Intima Media Thickness of the Proximal and Distal Common Carotids Correlation Between the Intima Media Thickness of the Proximal and Distal Common Carotids Leonard Hermann Roelke 1, Sergio Lamego Rodrigues 1, Paulo Andrade Lotufo 2, Jose Geraldo Mill 1 Universidade Federal

More information

Table S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416).

Table S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416). Table S1. Characteristics associated with frequency of nut (full entire sample; Nn=4,416). Daily nut Nn= 212 Weekly nut Nn= 487 Monthly nut Nn= 1,276 Infrequent or never nut Nn= 2,441 Sex; n (%) men 52

More information

Society for Behavioral Medicine 33 rd Annual Meeting New Orleans, LA

Society for Behavioral Medicine 33 rd Annual Meeting New Orleans, LA Society for Behavioral Medicine 33 rd Annual Meeting New Orleans, LA John M. Violanti, PhD* a ; LuendaE. Charles, PhD, MPH b ; JaK. Gu, MSPH b ; Cecil M. Burchfiel, PhD, MPH b ; Michael E. Andrew, PhD

More information

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Know Your Number Aggregate Report Single Analysis Compared to National Averages Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics

More information

Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up

Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up... Study Population: 340... Total Population: 500... Time Window of Baseline: 09/01/13 to 12/20/13... Time Window of Follow-up:

More information

Intima-Media Thickness

Intima-Media Thickness European Society of Cardiology Stockholm, 30th August 2010 Intima-Media Thickness Integration of arterial assessment into clinical practice Prof Arno Schmidt-Trucksäss, MD Institute of Exercise and Health

More information

Intermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis

Intermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis Intermediate Methods in Epidemiology 2008 Exercise No. 4 - Passive smoking and atherosclerosis The purpose of this exercise is to allow students to recapitulate issues discussed throughout the course which

More information

Introduction. Original Article

Introduction. Original Article 653356DVR0010.1177/1479164116653356Diabetes & Vascular Disease ResearchSitnik et al. research-article2016 Original Article Fasting glucose levels, incident diabetes, subclinical atherosclerosis and cardiovascular

More information

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein

More information

Clinical Investigations

Clinical Investigations Clinical Investigations Age, Gender, and Race-Based Coronary Artery Calcium Score Percentiles in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) Address for correspondence: Paulo A. Lotufo,

More information

Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes

Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes Katherine Baldock Catherine Chittleborough Patrick Phillips Anne Taylor August 2007 Acknowledgements This project was made

More information

Page 1. Disclosures. Background. No disclosures

Page 1. Disclosures. Background. No disclosures Population-Based Lipid Screening in the Era of a Childhood Obesity Epidemic: The Importance of Non-HDL Cholesterol Assessment Brian W. McCrindle, Cedric Manlhiot, Don Gibson, Nita Chahal, Helen Wong, Karen

More information

How would you manage Ms. Gold

How would you manage Ms. Gold How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE General practice Indicators for the NICE menu

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE General practice Indicators for the NICE menu NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE General practice Indicators for the NICE menu Indicator area: Pulse rhythm assessment for AF Indicator: NM146 Date: June 2017 Introduction There is evidence

More information

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Carmine Pizzi 1 ; Lamberto Manzoli 2, Stefano Mancini 3 ; Gigliola Bedetti

More information

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix to: Banks E, Crouch SR, Korda RJ, et al. Absolute risk of cardiovascular

More information

Statistical Fact Sheet Populations

Statistical Fact Sheet Populations Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total

More information

Which CVS risk reduction strategy fits better to carotid US findings?

Which CVS risk reduction strategy fits better to carotid US findings? Which CVS risk reduction strategy fits better to carotid US findings? Dougalis A, Soulaidopoulos S, Cholongitas E, Chalevas P, Vettas Ch, Doumtsis P, Vaitsi K, Diavasti M, Mandala E, Garyfallos A 4th Department

More information

Cho et al., 2009 Journal of Cardiology (2009), 54:

Cho et al., 2009 Journal of Cardiology (2009), 54: Endothelial Dysfunction, Increased Carotid Artery Intima-media Thickness and Pulse Wave Velocity, and Increased Level of Inflammatory Markers are Associated with Variant Angina Cho et al., 2009 Journal

More information

Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms

Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms QQ QR/RR n = 36 n = 80 Men (%) 20 (55) 54 (67) 0.216 Age (years) 57 ± 10 56 ±

More information

Central pressures and prediction of cardiovascular events in erectile dysfunction patients

Central pressures and prediction of cardiovascular events in erectile dysfunction patients Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,

More information

Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD

Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD 1 Preclinical? No symptoms No physical findings No diagnostic ECG findings No chest X-ray X findings No diagnostic events 2

More information

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen

More information

Glycemic and blood pressure control in older patients with hypertension and diabetes: association with carotid atherosclerosis

Glycemic and blood pressure control in older patients with hypertension and diabetes: association with carotid atherosclerosis Journal of Geriatric Cardiology (2011) 8: 24 30 2011 IGC All rights reserved; www.jgc301.com Research Articles Open Access Glycemic and blood pressure control in older patients with hypertension and diabetes:

More information

Visceral adipose tissue and carotid intimamedia thickness in HIV-infected patients undergoing cart: a prospective cohort study

Visceral adipose tissue and carotid intimamedia thickness in HIV-infected patients undergoing cart: a prospective cohort study Beires et al. BMC Infectious Diseases (2018) 18:32 DOI 10.1186/s12879-017-2884-9 RESEARCH ARTICLE Visceral adipose tissue and carotid intimamedia thickness in HIV-infected patients undergoing cart: a prospective

More information

SCIENTIFIC STUDY REPORT

SCIENTIFIC STUDY REPORT PAGE 1 18-NOV-2016 SCIENTIFIC STUDY REPORT Study Title: Real-Life Effectiveness and Care Patterns of Diabetes Management The RECAP-DM Study 1 EXECUTIVE SUMMARY Introduction: Despite the well-established

More information

Association between arterial stiffness and cardiovascular risk factors in a pediatric population

Association between arterial stiffness and cardiovascular risk factors in a pediatric population + Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro

More information

CVD risk assessment using risk scores in primary and secondary prevention

CVD risk assessment using risk scores in primary and secondary prevention CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities

More information

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention

More information

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic CVD Risk Assessment Michal Vrablík Charles University, Prague Czech Republic What is Risk? A cumulative probability of an event, usually expressed as percentage e.g.: 5 CV events in 00 pts = 5% risk This

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA Intern Med. Published online November 7, 2016.

More information

Supplementary Note Details of the patient populations studied Strengths and weakness of the study

Supplementary Note Details of the patient populations studied Strengths and weakness of the study Supplementary Note Details of the patient populations studied TVD and NCA patients. Patients were recruited to the TVD (triple vessel disease) group who had significant coronary artery disease (defined

More information

APPENDIX AVAILABLE ON THE HEI WEB SITE

APPENDIX AVAILABLE ON THE HEI WEB SITE APPENDIX AVAILABLE ON THE HEI WEB SITE Research Report 178 National Particle Component Toxicity (NPACT) Initiative Report on Cardiovascular Effects Sverre Vedal et al. Section 1: NPACT Epidemiologic Study

More information

Coronary artery disease (CAD) risk factors

Coronary artery disease (CAD) risk factors Background Coronary artery disease (CAD) risk factors CAD Risk factors Hypertension Insulin resistance /diabetes Dyslipidemia Smoking /Obesity Male gender/ Old age Atherosclerosis Arterial stiffness precedes

More information

Cardiometabolics in Children or Lipidology for Kids. Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az

Cardiometabolics in Children or Lipidology for Kids. Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az Cardiometabolics in Children or Lipidology for Kids Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az No disclosures for this Presentation Death Risk Approximately 40% of

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Solomon SD, Uno H, Lewis EF, et al. Erythropoietic response

More information

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study Panel Discussion: Literature that Should Have an Impact on our Practice: The Study Kaiser COAST 11 th Annual Conference Maui, August 2009 Robert Blumberg, MD, FACC Ralph Brindis, MD, MPH, FACC Primary

More information

Atherosclerotic Disease Risk Score

Atherosclerotic Disease Risk Score Atherosclerotic Disease Risk Score Kavita Sharma, MD, FACC Diplomate, American Board of Clinical Lipidology Director of Prevention, Cardiac Rehabilitation and the Lipid Management Clinics September 16,

More information

Title for Paragraph Format Slide

Title for Paragraph Format Slide Title for Paragraph Format Slide Presentation Title: Month Date, Year Atherosclerosis A Spectrum of Disease: February 12, 2015 Richard Cameron Padgett, MD Executive Medical Director, OHVI Pt RB Age 38

More information

Global Coronary Heart Disease Risk Assessment of U.S. Persons With the Metabolic. Syndrome. and Nathan D. Wong, PhD, MPH

Global Coronary Heart Disease Risk Assessment of U.S. Persons With the Metabolic. Syndrome. and Nathan D. Wong, PhD, MPH Diabetes Care Publish Ahead of Print, published online April 1, 2008 Global Coronary Heart Disease Risk Assessment of U.S. Persons With the Metabolic Syndrome Khiet C. Hoang MD, Heli Ghandehari, BS, Victor

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and

More information

AUTONOMIC FUNCTION IS A HIGH PRIORITY

AUTONOMIC FUNCTION IS A HIGH PRIORITY AUTONOMIC FUNCTION IS A HIGH PRIORITY 1 Bladder-Bowel-AD Tetraplegia Sexual function Walking Bladder-Bowel-AD Paraplegia Sexual function Walking 0 10 20 30 40 50 Percentage of respondents an ailment not

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Leibowitz M, Karpati T, Cohen-Stavi CJ, et al. Association between achieved low-density lipoprotein levels and major adverse cardiac events in patients with stable ischemic

More information

The Whitehall II study originally comprised 10,308 (3413 women) individuals who, at

The Whitehall II study originally comprised 10,308 (3413 women) individuals who, at Supplementary notes on Methods The study originally comprised 10,308 (3413 women) individuals who, at recruitment in 1985/8, were London-based government employees (civil servants) aged 35 to 55 years.

More information

The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India

The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India eissn: 09748369, www.biolmedonline.com The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India M Estari, AS Reddy, T Bikshapathi,

More information

The Framingham Coronary Heart Disease Risk Score

The Framingham Coronary Heart Disease Risk Score Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Although

More information

egfr > 50 (n = 13,916)

egfr > 50 (n = 13,916) Saxagliptin and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations from the SAVOR-TIMI 53 Trial Supplementary Table 1. Characteristics according

More information

HDL and Arterial Wall

HDL and Arterial Wall JIFA January 31th 2014 HDL and Arterial Wall P-J TOUBOUL INSERM698 Bichat University Conflict of Interest M Ath intellectual property owner Involvement in R & D for atherosclerosis software developments

More information

ARIC Manuscript Proposal #1233. PC Reviewed: 4_/_10/07 Status: _A Priority: 2_ SC Reviewed: Status: Priority:

ARIC Manuscript Proposal #1233. PC Reviewed: 4_/_10/07 Status: _A Priority: 2_ SC Reviewed: Status: Priority: ARIC Manuscript Proposal #1233 PC Reviewed: 4_/_10/07 Status: _A Priority: 2_ SC Reviewed: Status: Priority: 1.a. Full Title: Subclinical atherosclerosis precedes type 2 diabetes in the ARIC study cohort

More information

3/25/2010. Age-adjusted incidence rates for coronary heart disease according to body mass index and waist circumference tertiles

3/25/2010. Age-adjusted incidence rates for coronary heart disease according to body mass index and waist circumference tertiles Outline Relationships among Regional Adiposity, Physical Activity, and CVD Risk Factors: Preliminary Results from Two Epidemiologic Studies Molly Conroy, MD, MPH Obesity Journal Club February 18, 2010

More information

Bariatric Surgery versus Intensive Medical Therapy for Diabetes 3-Year Outcomes

Bariatric Surgery versus Intensive Medical Therapy for Diabetes 3-Year Outcomes The new england journal of medicine original article Bariatric Surgery versus Intensive Medical for Diabetes 3-Year Outcomes Philip R. Schauer, M.D., Deepak L. Bhatt, M.D., M.P.H., John P. Kirwan, Ph.D.,

More information

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Sao Paulo Medical School Sao Paolo, Brazil Subclinical atherosclerosis in CVD risk: Stratification & management Prof.

More information

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC Am J Cardiol (2004);94:729-32 Relation of degree of physical activity to coronary artery calcium score in asymptomatic individuals with multiple metabolic risk factors M. Y. Desai, et al. Ciccarone Preventive

More information

Risk Factors for Heart Disease

Risk Factors for Heart Disease Risk Factors for Heart Disease Risk Factors we cannot change (Age, Gender, Family History) Risk Factors we can change (modifiable) Smoking Blood pressure Cholesterol Diabetes Inactivity Overweight Stress

More information

Diabetes Care 31: , 2008

Diabetes Care 31: , 2008 Cardiovascular and Metabolic Risk O R I G I N A L A R T I C L E Global Coronary Heart Disease Risk Assessment of Individuals With the Metabolic Syndrome in the U.S. KHIET C. HOANG, MD HELI GHANDEHARI VICTOR

More information

Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography

Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography Hyo Eun Park 1, Eun-Ju Chun 2, Sang-Il Choi 2, Soyeon Ahn 2, Hyung-Kwan Kim 3,

More information

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,

More information

Original Research Article

Original Research Article A STUDY TO ESTIMATE SUBCLINICAL ATHEROSCLEROSIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS BY MEASURING THE CAROTID INTIMAL MEDIAL THICKNESS Natarajan Kandasamy 1, Rajan Ganesan 2, Thilakavathi Rajendiran

More information

Improved control for confounding using propensity scores and instrumental variables?

Improved control for confounding using propensity scores and instrumental variables? Improved control for confounding using propensity scores and instrumental variables? Dr. Olaf H.Klungel Dept. of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences

More information

2013 Hypertension Measure Group Patient Visit Form

2013 Hypertension Measure Group Patient Visit Form Please complete the form below for 20 or more unique patients meeting patient sample criteria for the measure group for the current reporting year. A majority (11 or more) patients must be Medicare Part

More information

Clinical Trial Synopsis TL-OPI-518, NCT#

Clinical Trial Synopsis TL-OPI-518, NCT# Clinical Trial Synopsis, NCT# 00225264 Title of Study: A Double-Blind, Randomized, Comparator-Controlled Study in Subjects With Type 2 Diabetes Mellitus Comparing the Effects of Pioglitazone HCl vs Glimepiride

More information

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD

More information

Impact of self-reported fasting duration on lipid profile variability, cardiovascular risk stratification and metabolic syndrome diagnosis

Impact of self-reported fasting duration on lipid profile variability, cardiovascular risk stratification and metabolic syndrome diagnosis original article Impact of self-reported fasting duration on lipid profile variability, cardiovascular risk stratification and metabolic syndrome diagnosis Carolina Castro Porto Silva Janovsky 1, Antonio

More information

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION 2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL

More information

CVD Prevention, Who to Consider

CVD Prevention, Who to Consider Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..

More information

Cardio-metabolic diseases are the epidemics of our time,

Cardio-metabolic diseases are the epidemics of our time, Leisure Time Physical Activity and Cardio-Metabolic Health: Results From the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) Xiaochen Lin, MS; Sheila M. Alvim, PhD; Eduardo J. Simoes, MD, DLSHTM,

More information

Correlation of novel cardiac marker

Correlation of novel cardiac marker Correlation of novel cardiac marker and mortality in EGAT population. Soluble ST2 hscrp Poh Chanyavanich, MD SukitYamwong, MD Piyamitr Sritara, MD Ramathibodi hospital Background hscrp - the most widely

More information

CAROTID INTIMA-MEDIA THICKNESS. Dimitrios N. Nikas, MD, PhD, FESC Interventional Cardiologist Ioannina University Hospital

CAROTID INTIMA-MEDIA THICKNESS. Dimitrios N. Nikas, MD, PhD, FESC Interventional Cardiologist Ioannina University Hospital CAROTID INTIMA-MEDIA THICKNESS Dimitrios N. Nikas, MD, PhD, FESC Interventional Cardiologist Ioannina University Hospital I, DIMITRIOS N. NIKAS, MD, PHD, FESC, HAVE NO CONFLICT OF INTEREST TO DECLARE RELATED

More information

Review of guidelines for management of dyslipidemia in diabetic patients

Review of guidelines for management of dyslipidemia in diabetic patients 2012 international Conference on Diabetes and metabolism (ICDM) Review of guidelines for management of dyslipidemia in diabetic patients Nan Hee Kim, MD, PhD Department of Internal Medicine, Korea University

More information

Risk Assessment of developing type 2 diabetes mellitus in patient on antihypertensive medication

Risk Assessment of developing type 2 diabetes mellitus in patient on antihypertensive medication 41 Research Article Risk Assessment of developing type 2 diabetes mellitus in patient on antihypertensive medication Amarjeet Singh*, Sudeep bhardwaj, Ashutosh aggarwal Department of Pharmacology, Seth

More information

Total risk management of Cardiovascular diseases Nobuhiro Yamada

Total risk management of Cardiovascular diseases Nobuhiro Yamada Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible

More information

Individual Study Table Referring to Item of the Submission: Volume: Page:

Individual Study Table Referring to Item of the Submission: Volume: Page: 2.0 Synopsis Name of Company: Abbott Laboratories Name of Study Drug: Meridia Name of Active Ingredient: Sibutramine hydrochloride monohydrate Individual Study Table Referring to Item of the Submission:

More information

Since 1980, obesity has more than doubled worldwide, and in 2008 over 1.5 billion adults aged 20 years were overweight.

Since 1980, obesity has more than doubled worldwide, and in 2008 over 1.5 billion adults aged 20 years were overweight. Impact of metabolic comorbidity on the association between body mass index and health-related quality of life: a Scotland-wide cross-sectional study of 5,608 participants Dr. Zia Ul Haq Doctoral Research

More information

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Ischemic Heart and Cerebrovascular Disease Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Relationships Between Diabetes and Ischemic Heart Disease Risk of Cardiovascular Disease in Different Categories

More information

Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese

Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese Diabetes Care Publish Ahead of Print, published online June 12, 2008 Raised Blood Pressure and Dysglycemia Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese Bernard My Cheung,

More information

Supplementary Online Content. Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and

Supplementary Online Content. Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and 1 Supplementary Online Content 2 3 4 5 6 Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and cardiometabolic risk factor management on sympton burden and severity in patients with atrial

More information

RELATIONSHIP OF CLINICAL FACTORS WITH ADIPONECTIN AND LEPTIN IN CHILDREN WITH NEWLY DIAGNOSED TYPE 1 DIABETES. Yuan Gu

RELATIONSHIP OF CLINICAL FACTORS WITH ADIPONECTIN AND LEPTIN IN CHILDREN WITH NEWLY DIAGNOSED TYPE 1 DIABETES. Yuan Gu RELATIONSHIP OF CLINICAL FACTORS WITH ADIPONECTIN AND LEPTIN IN CHILDREN WITH NEWLY DIAGNOSED TYPE 1 DIABETES by Yuan Gu BE, Nanjing Institute of Technology, China, 2006 ME, University of Shanghai for

More information

Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use

Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use Baseline characteristics Users (n = 28) Non-users (n = 32) P value Age (years) 67.8 (9.4) 68.4 (8.5)

More information

journal of medicine The new england Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein Abstract

journal of medicine The new england Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein Abstract The new england journal of medicine established in 1812 november 20, 2008 vol. 359 no. 21 to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein Paul M Ridker, M.D., Eleanor Danielson,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Basaria S, Harman SM, Travison TG, et al. The effects of testosterone administration for three years on subclinical atherosclerosis progression in older men with low or low

More information

Effects of Bariatric Surgery in Obese Patients with Hypertension The GATEWAY Randomized Trial

Effects of Bariatric Surgery in Obese Patients with Hypertension The GATEWAY Randomized Trial Effects of Bariatric Surgery in Obese Patients with Hypertension The GATEWAY Randomized Trial Carlos Aurelio Schiavon, MD, FACS On behalf of the GATEWAY Executive Committee and Investigators DISCLOSURE

More information

Non alcoholic fatty liver disease and atherosclerosis Raul Santos, MD

Non alcoholic fatty liver disease and atherosclerosis Raul Santos, MD Non alcoholic fatty liver disease and atherosclerosis Raul Santos, MD Sao Paulo Medical School Hospital Sao Paulo, Brazil Disclosure Honoraria received for consult and/or speaker : Astra Zeneca, Amgen,

More information

The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009

The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009 The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009 Learning Objectives 1. Understand the role of statin therapy in the primary and secondary prevention of stroke 2. Explain

More information

CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES

CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES C. Liakos, 1 G. Vyssoulis, 1 E. Karpanou, 2 S-M. Kyvelou, 1 V. Tzamou, 1 A. Michaelides, 1 A. Triantafyllou, 1 P. Spanos, 1 C. Stefanadis

More information

Case Discussions: Treatment Strategies for High Risk Populations. Most Common Reasons for Referral to the Baylor Lipid Clinic

Case Discussions: Treatment Strategies for High Risk Populations. Most Common Reasons for Referral to the Baylor Lipid Clinic Case Discussions: Treatment Strategies for High Risk Populations Peter H. Jones MD, FNLA Associate Professor Methodist DeBakey Heart and Vascular Center Baylor College of Medicine Most Common Reasons for

More information

Flatter Diurnal Cortisol Slope on Workdays is Associated with Pre-clinical Atherosclerosis

Flatter Diurnal Cortisol Slope on Workdays is Associated with Pre-clinical Atherosclerosis Flatter Diurnal Cortisol Slope on Workdays is Associated with Pre-clinical Atherosclerosis Karissa G. Miller, B.A., Thomas W. Kamarck, Ph.D., Matthew F. Muldoon, M.D., Peter J. Gianaros, Ph.D., & Stephen

More information

Correspondence should be addressed to Huijuan Zhang;

Correspondence should be addressed to Huijuan Zhang; Hindawi Diabetes Research Volume 2017, Article ID 3510275, 6 pages https://doi.org/10.1155/2017/3510275 Research Article Serum 25-Hydroxyvitamin D3 Levels Are Associated with Carotid Intima-Media Thickness

More information

Simvastatin With or Without Ezetimibe in Familial Hypercholesterolemia

Simvastatin With or Without Ezetimibe in Familial Hypercholesterolemia Simvastatin With or Without Ezetimibe in Familial Hypercholesterolemia The trial ClinicalTrials.gov number: NCT00552097 John J.P. Kastelein, MD, PhD* Department of Vascular Medicine Academic Medical Center

More information

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients 2012 International Conference on Life Science and Engineering IPCBEE vol.45 (2012) (2012) IACSIT Press, Singapore DOI: 10.7763/IPCBEE. 2012. V45. 14 Impact of Physical Activity on Metabolic Change in Type

More information

Table S2: Anthropometric, clinical, cardiovascular and appetite outcome changes over 8 weeks (baseline-week 8) by snack group

Table S2: Anthropometric, clinical, cardiovascular and appetite outcome changes over 8 weeks (baseline-week 8) by snack group Table S1: Nutrient composition of cracker and almond snacks Cracker* Almond** Weight, g 77.5 g (5 sheets) 56.7 g (2 oz.) Energy, kcal 338 364 Carbohydrate, g (kcal) 62.5 12.6 Dietary fiber, g 2.5 8.1 Protein,

More information

Statistical Analysis Plan FINAL. DexComG4 (DexCom Corporation) CGMMDI GOLD-Study

Statistical Analysis Plan FINAL. DexComG4 (DexCom Corporation) CGMMDI GOLD-Study 1.0 Page 1 of 15 FINAL DexComG4 (DexCom Corporation) CGMMDI GOLD-Study monitoring (CGM) in individuals with type 1 diabetes treated 2016-07-07 Approvals Name/Title: Nils-Gunnar Pehrsson / Statistiska Konsultgruppen,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Larsen JR, Vedtofte L, Jakobsen MSL, et al. Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia

More information

Imaging Biomarkers: utilisation for the purposes of registration. EMEA-EFPIA Workshop on Biomarkers 15 December 2006

Imaging Biomarkers: utilisation for the purposes of registration. EMEA-EFPIA Workshop on Biomarkers 15 December 2006 Imaging Biomarkers: utilisation for the purposes of registration EMEA-EFPIA Workshop on Biomarkers 15 December 2006 Vascular Imaging Technologies Carotid Ultrasound-IMT IVUS-PAV QCA-% stenosis 2 ICH E

More information

Effects of Bariatric Surgery in Obese Patients with Hypertension The GATEWAY Randomized Trial

Effects of Bariatric Surgery in Obese Patients with Hypertension The GATEWAY Randomized Trial Effects of Bariatric Surgery in Obese Patients with Hypertension The GATEWAY Randomized Trial Carlos Aurelio Schiavon, MD, FACS On behalf of the GATEWAY Executive Committee and Investigators DISCLOSURE

More information

ISSN: X Impact factor: 4.295

ISSN: X Impact factor: 4.295 ISSN: 2454-132X Impact factor: 4.295 (Volume3, Issue1) Available online at: www.ijariit.com A Cross Sectional Study for Evaluation of Association between Hypertensive Retinopathy with Serum Lipid Profile

More information

Comparability of patient-reported health status: multi-country analysis of EQ-5D responses in patients with type 2 diabetes

Comparability of patient-reported health status: multi-country analysis of EQ-5D responses in patients with type 2 diabetes Comparability of patient-reported health status: multi-country analysis of EQ-5D responses in patients with type 2 diabetes Joshua A Salomon, Anushka Patel, Bruce Neal, Paul Glasziou, Diederick E. Grobbee,

More information

Short stature is an inflammatory disadvantage among middle-aged Japanese men

Short stature is an inflammatory disadvantage among middle-aged Japanese men Environ Health Prev Med (2016) 21:361 367 DOI 10.1007/s12199-016-0538-y REGULAR ARTICLE Short stature is an inflammatory disadvantage among middle-aged Japanese men Yuji Shimizu 1,2 Hiroyuki Yoshimine

More information

Cost-effectiveness of pravastatin for primary prevention of coronary artery disease in Japan Nagata-Kobayashi S, Shimbo T, Matsui K, Fukui T

Cost-effectiveness of pravastatin for primary prevention of coronary artery disease in Japan Nagata-Kobayashi S, Shimbo T, Matsui K, Fukui T Cost-effectiveness of pravastatin for primary prevention of coronary artery disease in Japan Nagata-Kobayashi S, Shimbo T, Matsui K, Fukui T Record Status This is a critical abstract of an economic evaluation

More information

Although the prevalence and incidence of type 2 diabetes mellitus

Although the prevalence and incidence of type 2 diabetes mellitus n clinical n Validating the Framingham Offspring Study Equations for Predicting Incident Diabetes Mellitus Gregory A. Nichols, PhD; and Jonathan B. Brown, PhD, MPP Background: Investigators from the Framingham

More information